Which CGRP mAb is given by IV infusion every 12 weeks?

Which CGRP mAb is given by IV infusion every 12 weeks?

• A. Erenumab
• B. Eptinezumab
• C. Fremanezumab
• D. Galcanezumab

Answer: (B)

The key idea is how each CGRP monoclonal antibody is given and how often. Among these therapies, only one is delivered by intravenous infusion on a fixed 12-week schedule. That drug is given as a 30-minute IV infusion every 12 weeks (commonly at 300 mg), making it the IV option with a quarterly schedule. The other three are administered by subcutaneous injections, with monthly dosing being the typical pattern (and one offering an option for quarterly subcutaneous dosing but not IV). So the IV infusion every 12 weeks aligns specifically with the IV-delivered, quarterly regimen.

The key idea is how each CGRP monoclonal antibody is given and how often. Among these therapies, only one is delivered by intravenous infusion on a fixed 12-week schedule. That drug is given as a 30-minute IV infusion every 12 weeks (commonly at 300 mg), making it the IV option with a quarterly schedule. The other three are administered by subcutaneous injections, with monthly dosing being the typical pattern (and one offering an option for quarterly subcutaneous dosing but not IV). So the IV infusion every 12 weeks aligns specifically with the IV-delivered, quarterly regimen.